Although the molecular mechanisms underlying ME/CFS remain incompletely understood, recent findings [5] suggest that microglial activation observed in ME/CFS may be mediated, in part, by the interaction of advanced glycation end products (AGEs) with their receptor, RAGE. Here, AGER is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.